The IN.PACT Admiral device will provide a new treatment option for PAD patients.
The cognitive app that aims to make daily diabetes management easier and more informative is in the final development stage.
Medtronic wins FDA approval for the world’s smallest pacemaker.
Cultivating fresh thinking and continual adaptation is key.
Announced at CES 2016, the cognitive app will leverage predictive analytics to help patients better manage their condition.
A review of the articles you found most interesting this year.
The company will invest €13 million in the facility, which will make drug-coated balloons for peripheral artery disease.
Meaningful data integration and patient empowerment are driving next-generation diabetes technology.
The company’s Bakken Research Centre in the Netherlands is centrally located for technology development and collaboration with physicians.
There is no such thing as minimum or maximum compliance—there is just compliance.